-
Taxonomy & unit
-
us-gaap: CNY and USD
-
Description
-
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
-
Summary
-
Gracell Biotechnologies Inc. quarterly Assets history and growth rate from Q4 2020 to Q2 2023.
- Gracell Biotechnologies Inc. Assets for the quarter ending June 30, 2023 was $190M, a 33% decline year-over-year.
Assets, Quarterly (USD)
Assets, YoY Quarterly Growth (%)